Skip to main content
Sign In

Mary Reyland, PhD

Professor and Director for the Cancer Biology Graduate Training Program

Primary Appointment:

  • Department of Craniofacial Biology , School of Dental Medicine

Secondary Appointment:

  • Department of Pathology, Medical School


  • BS, George Mason University, Fairfax, Virginia
  • PhD, Medical College of Virginia

Postdoctoral Education:

  • Department of Pathology, University of Washington, Seattle, Washington


  • Molecular Biology
  • Cancer Biology
  • Cell Biology, Stem Cells and Development

Research Activities:

  • Protein Kinase C and Salivary Gland Apoptosis

Departmentmental Affiliations:

  • Cellular and Developmental Biology
  • Pathology

Selected Publications:

  • B Allen-Petersen*, AR Miller*, SM Anderson, MC Neville, KI Nakayama and ME Reyland 2010. Loss of Protein Kinase Cdelta alters mammary gland development and apoptosis, *equal contributions. Cell Death and Disease 1:1-9
  • ME Reyland and AP Bradford 2010. PKC isoforms and the control of apoptosis. MG Kazanietz (ed.), Protein Kinase C in Cancer Signaling and Therapy, DOI 10.1007/978-1-60761-543-9_9
  • A Vissink, JB Mitchell, BJ Baum, KH Limesand, S Beier-Jensen, PC Fox, LS Elting, JA Langendijk, RP Coppes, and ME Reyland 2010. Oral Complications of Emerging Cancer Therapies. Int J Rad Biology Biophysics 78:983-91
  • JM Symonds, AM Ohm, CJ Carter, LE Heasley, TA Aly, WA Franklin and ME Reyland 2011. Protein kinase Cdelta is a downstream effector of oncogenic KRAS in K-Ras-dependent lung tumors. Cancer Res 71:2087-2097
  • TS Adwan, AM Ohm, DNM Jones, MJ Humphries and ME Reyland 2011. Regulated Binding of Importin-alpha to PKCdelta in Response to Apoptotic Signals Facilitates  Nuclear Import.  J Biol Chem, 286:35716-35724​